the Effect of Integrated Neuomuscular Inhibition Technique on Adult Females With Cervicogenic Headache

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 16, 2025

Primary Completion Date

October 14, 2025

Study Completion Date

October 14, 2025

Conditions
Cervicogenic Headache
Interventions
DRUG

Muscle relaxants tizanidine

All patients will receive a traditional medical program by an experienced neurologist in the form of Muscle relaxants tizanidine ,4 mg to 32 mg, Three times a day for one month .

OTHER

integrated neuromuscular inhibition technique

Patients in experimental group (B) will receive the same program as control group (A) plus the INIT for upper trapezius and suboccipital muscles. The INIT program will be administrated three times a week for one month .

Trial Locations (1)

6620010

RECRUITING

Khalid enb elwaleed polyclinic, Tanta

All Listed Sponsors
lead

Kafrelsheikh University

OTHER

NCT07025187 - the Effect of Integrated Neuomuscular Inhibition Technique on Adult Females With Cervicogenic Headache | Biotech Hunter | Biotech Hunter